Abstract
We have previously demonstrated the presence of a progestagen-associated endometrial protein (PEP) in women. In this communication, we report the development of a RIA for PEP. We describe the use of this method for determining changes in PEP concentration that occur in the endometrium, amniotic fluid, and serum during the normal menstrual cycle and pregnancy. This assay used a partially purified PEP as the reference standard, purified radioiodinated PEP as the tracer, and a goat antibody to PEP as the specific antibody. The assay appears to be highly specific, since the tracer did not bind to antibodies to several known pregnancy-associated plasma, uterine, or placental proteins, including human transferrin, α1-anti-trypsin, ceruloplasmin, human PRL, placental protein SP1, pregnancy zone protein, α-fetoprotein, hCG, pregnancy-associated plasma proteins, and rabbit uteroglobin. Also, hCG, human PRL, and rabbit uteroglobin did not compete for the binding of the tracer to anti-PEP. The detection threshold of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.